Decreasing DNA sequencing costs propel health genomics, leading to a global surge in data collection initiatives. This data empowers researchers to link genes to disease risk, enabling earlier diagnoses, preventative actions, and personalized treatments. Companion diagnostics development and accelerated drug discovery are further benefits. Data sharing, healthcare professional education, and ensuring equitable access for all populations remain key challenges.